Epstein-Barr Virus Early Antigen Recombinant
$800.00 – $1,100.00
| accession | P03191 |
| Source | DNA sequence encoding immunodominant fragment of Epstein-Barr Early Antigen expressed in Escherichia Coli. |
| Molecular weight | Recombinant EBV EA encodes the C terminal immunodominant sequence (306-390) of the Epstein-Barr Virus Early Antigen protein D BMRF1. Recombinant EBV EA contains an N terminal GST purification tag and migrates as an approximately 36 kDa protein under non-reducing conditions conditions in SDS-PAGE. |
| Purity | >90%, as determined by SDS-PAGE. |
| Applications | Recombinant human EBV EA antigen is suitable for ELISA and Western blots, excellent antigen for detection of EBV with minimal specificity problems. |
| Presentation | 50mM Tris-HCl pH 8, 10mM glutathione, 60mM NaCl and 50% Glycerol. |
| Storage | This protein can be stored in working aliquots at 2° - 8° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
| Usage | This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
| Biological Process | Transcription |
| Molecular function | Activator |
| Molecular function | DNA-binding |